Allecra’s Exblifep secures FDA approval for cUTI treatment
The FDA approved Exblifep (cefepime/enmetazobactam) based on a comprehensive set of clinical data showing the drug's efficacy against…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Feb 24
The FDA approved Exblifep (cefepime/enmetazobactam) based on a comprehensive set of clinical data showing the drug's efficacy against…
28 Feb 24
The BTD for NVL-520 is based on the preliminary safety and activity of NVL-520 in heavily pretreated patients…
26 Feb 24
In the trial, a 16-week course of omalizumab enhanced the quantity of peanut, tree nut, egg, milk, and…
26 Feb 24
The typhoid vaccine was developed under a collaborative effort between the company and the International Vaccine Institute and…
23 Feb 24
Blueprint Medicines will be paid a purchase price of $15m, of which $10m is due upon Rigel's first…
22 Feb 24
A Phase 1 dosage expansion clinical trial combining IO-202 with azacitidine is presently enrolling newly diagnosed CMML patients…
22 Feb 24
The bispecific antibody is intended to connect B-cell maturation antigen on various myeloma cells with CD3-expressing T cells…
20 Feb 24
The fast-track status was based on findings of the previously announced Phase 2 trial that showed a clinically…
19 Feb 24
Under the agreement, Apotex will seek market approval in Canada for VEVYE, IHEEZO, and ZERVIATE in Canada, and…
Patient CarePharmaceuticals and MedicinesPartnerships and Licensing Agreements
19 Feb 24
Amtagvi is a prescription-based tumour-derived autologous T cell immunotherapy and is said to be the first and the…